Zymeworks Financial Statements From 2010 to 2026

Zymeworks Common Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 353.3 M 532.6 M 271.8 M Slightly volatile Other Current Liabilities 43.9 M 62.9 M 34.3 M Slightly volatile Total Current Liabilities 55.7 M 101.5 M 44.6 M Slightly volatile Other Liabilities 22.5 M 40.7 M 18.7 M Slightly volatile Property Plant And Equipment Net 22.5 M 39.5 M 17 M Slightly volatile Accounts Payable 4.6 M 4.5 M 3.6 M Slightly volatile Cash 135 M 76 M 102.8 M Slightly volatile Non Current Assets Total 196.4 M 187 M 70.3 M Slightly volatile Cash And Short Term Investments 246 M 259.6 M 185.5 M Slightly volatile Net Receivables 67.4 M 64.2 M 17.5 M Slightly volatile Common Stock Shares Outstanding 46 M 87.3 M 39.6 M Slightly volatile Inventory 0.8 0.9 0.9824 Slightly volatile Other Current Assets 11 M 21.7 M 8.4 M Slightly volatile Total Liabilities 96.7 M 143 M 73.6 M Slightly volatile Short and Long Term Debt 67.7 K 71.3 K 310.6 K Very volatile Total Current Assets 272.4 M 345.5 M 208.4 M Slightly volatile Short Term Debt 3.3 M 3.2 M 1.3 M Slightly volatile Intangible Assets 5 M 5.3 M 11.5 M Slightly volatile Common Stock 1.2 B 1.2 B 494.6 M Slightly volatile Property Plant Equipment 57.5 M 54.8 M 19.4 M Slightly volatile Short and Long Term Debt Total 13.8 M 21.3 M 9.5 M Slightly volatile Current Deferred Revenue 19.5 M 29.4 M 14.1 M Slightly volatile Common Stock Total Equity 894.9 M 852.3 M 414 M Slightly volatile Short Term Investments 122.2 M 183.6 M 84.4 M Slightly volatile Non Current Liabilities Total 45.2 M 41.4 M 29.3 M Slightly volatile Capital Surpluse 238.7 M 227.4 M 92.4 M Slightly volatile Deferred Long Term Liabilities 22.5 M 20.3 M 14.3 M Slightly volatile Property Plant And Equipment Gross 34.9 M 60 M 24 M Slightly volatile Long Term Debt 44.5 K 46.8 K 1.8 M Slightly volatile Good Will 9.6 M 10.8 M 11.8 M Slightly volatile Long Term Debt Total 39.3 K 41.4 K 1.8 M Slightly volatile Capital Lease Obligations 15.9 M 21.3 M 9.9 M Slightly volatile Preferred Stock Total Equity 47.1 M 53 M 57.8 M Slightly volatile Non Current Liabilities Other 977.8 K 1 M 3.1 M Pretty Stable Net Invested Capital 352.9 M 389.6 M 242.6 M Slightly volatile Net Working Capital 294.9 M 244 M 189.9 M Slightly volatile Capital Stock 812.9 M 1.2 B 572 M Slightly volatile Deferred Long Term Asset Charges 716.1 K 1.4 M 598.9 K Slightly volatile
Zymeworks Common Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Depreciation And Amortization 7.1 M 12.9 M 5.4 M Slightly volatile Interest Expense 5.8 M 4.1 M 3.8 M Slightly volatile Selling General Administrative 43.8 M 70.7 M 33.4 M Slightly volatile Total Revenue 78.7 M 87.7 M 56.5 M Slightly volatile Other Operating Expenses 159.7 M 245.4 M 121.1 M Slightly volatile Research Development 114.6 M 154.8 M 86.2 M Slightly volatile Cost Of Revenue 12.2 M 12.9 M 63.9 M Slightly volatile Total Operating Expenses 133.6 M 245.4 M 104.3 M Slightly volatile Interest Income 24.1 M 22.9 M 6.7 M Slightly volatile Non Recurring 1.1 M 883.2 K 836.9 K Pretty Stable Reconciled Depreciation 10.5 M 12.9 M 7 M Slightly volatile Selling And Marketing Expenses 74.2 B 70.7 B 12.1 B Slightly volatile
Zymeworks Common Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Stock Based Compensation 14.2 M 20.5 M 10.5 M Slightly volatile Begin Period Cash Flow 129.3 M 181.2 M 96.4 M Slightly volatile Depreciation 7.6 M 12.9 M 5.8 M Slightly volatile Capital Expenditures 6.7 M 3.5 M 4.6 M Slightly volatile End Period Cash Flow 135 M 76 M 102.8 M Slightly volatile Dividends Paid 983.1 M 936.3 M 304.9 M Slightly volatile
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Price To Sales Ratio 15.9 16.74 61.3285 Slightly volatile Days Sales Outstanding 168 307 283 Slightly volatile Book Value Per Share 3.87 4.02 4.0679 Slightly volatile Stock Based Compensation To Revenue 0.44 0.27 0.3788 Very volatile Capex To Depreciation 0.3 0.32 1.0977 Pretty Stable EV To Sales 15.22 16.02 51.6165 Slightly volatile Payables Turnover 14.84 20.72 16.282 Slightly volatile Sales General And Administrative To Revenue 1.2 0.93 1.3872 Slightly volatile Research And Ddevelopement To Revenue 3.54 2.03 4.1871 Slightly volatile Capex To Revenue 0.0439 0.0462 0.1703 Pretty Stable Cash Per Share 3.88 2.68 4.0792 Slightly volatile Days Payables Outstanding 27.6 18.24 31.766 Slightly volatile Intangibles To Total Assets 0.0391 0.0412 0.0718 Pretty Stable Current Ratio 3.91 3.06 4.6522 Very volatile Receivables Turnover 1.49 1.57 12.8436 Very volatile Capex Per Share 0.0346 0.0364 0.1043 Pretty Stable Revenue Per Share 1.15 0.91 1.0759 Slightly volatile Interest Debt Per Share 0.18 0.22 0.1634 Slightly volatile Debt To Assets 0.0236 0.036 0.021 Slightly volatile Graham Number 14.41 16.21 17.6951 Slightly volatile Operating Cycle 168 307 283 Slightly volatile Days Of Payables Outstanding 27.6 18.24 31.766 Slightly volatile Ebt Per Ebit 1.08 0.98 0.9953 Slightly volatile Long Term Debt To Capitalization 0.26 0.3 0.3234 Slightly volatile Quick Ratio 3.91 3.06 4.6522 Very volatile Net Income Per E B T 0.79 0.95 0.9823 Slightly volatile Cash Ratio 0.82 0.86 2.667 Slightly volatile Days Of Sales Outstanding 168 307 283 Slightly volatile Fixed Asset Turnover 5.02 2.56 4.1775 Very volatile Debt Ratio 0.0236 0.036 0.021 Slightly volatile Price Sales Ratio 15.9 16.74 61.3285 Slightly volatile Asset Turnover 0.17 0.15 0.1636 Slightly volatile
Zymeworks Common Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 788.7 M 999.4 M 635.6 M Slightly volatile Enterprise Value 673.4 M 956.5 M 543.6 M Slightly volatile

Zymeworks Fundamental Market Drivers

Zymeworks Upcoming Events

About Zymeworks Common Financial Statements

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zymeworks Common Stock is a strong investment it is important to analyze Zymeworks Common's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Zymeworks Common's future performance. For an informed investment choice regarding Zymeworks Stock, refer to the following important reports:

How To Invest In Zymeworks Details

Is Zymeworks Stock a good investment? Details

What is Zymeworks Common's Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details